Prosecution Insights
Last updated: July 17, 2026
Application No. 18/755,421

PERSONALIZED HEALTH COACHING SYSTEM

Final Rejection §101
Filed
Jun 26, 2024
Priority
Oct 03, 2019 — provisional 62/910,205 +2 more
Examiner
EGLOFF, PETER RICHARD
Art Unit
3715
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Willow Laboratories Inc.
OA Round
2 (Final)
43%
Grant Probability
Moderate
3-4
OA Rounds
1y 3m
Est. Remaining
75%
With Interview

Examiner Intelligence

Grants 43% of resolved cases
43%
Career Allowance Rate
336 granted / 786 resolved
-27.3% vs TC avg
Strong +32% interview lift
Without
With
+32.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
31 currently pending
Career history
826
Total Applications
across all art units

Statute-Specific Performance

§101
15.2%
-24.8% vs TC avg
§103
74.8%
+34.8% vs TC avg
§102
4.9%
-35.1% vs TC avg
§112
4.0%
-36.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 786 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections – 35 USC § 101 2. 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 2-21 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Independent claims 2 and 17 recites a method comprising: assigning a first classification to a glucose response of a user based at least in part on a plurality of measured glucose values, wherein the first classification comprises at least one of: low variability, moderate variability, or severe variability; applying a bias correction to the plurality of glucose values based the first classification to generate a bias-corrected plurality of measured glucose values; receiving input pertaining to a glucose-changing event; determining a glucose response score based on the bias-corrected plurality of measured glucose values and the input pertaining to the glucose-changing event; and providing a recommendation relating to the glucose-changing event based on the glucose response score. The limitations of assigning a classification, applying a bias correction, receiving input, determining a glucose response score, and providing a recommendation, as drafted, constitutes a process that, under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components. That is, other than reciting the steps are performed by “one or more hardware processors”, and the providing constitutes outputting “to a display”, nothing in the claim elements precludes the steps from practically being performed in the mind. For example, but for the “hardware processors” and “display” language, “assigning” “applying”, “receiving”, “determining” and “outputting” in the context of this claim encompasses a user manually assigning a classification and applying a bias correction, receiving inputs, making a determination, and providing the recommendation, for example using a pen and paper. If a claim limitation, under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components, then it falls within the “Mental Processes” grouping of abstract ideas. Accordingly, the claims recite an abstract idea. This judicial exception is not integrated into a practical application. In particular, the claim only recites using one or more hardware processors and a display to perform the claimed steps. The processors and display in these steps are recited at a high-level of generality (i.e., as a generic processor and display performing generic computer functions of receiving input, making determinations, and displaying information) such that they amount to no more than mere instructions to apply the exception using generic computer components. Accordingly, these additional elements do not integrate the abstract idea into a practical application because they do not impose any meaningful limits on practicing the abstract idea. The claims further recite measuring, using a glucose sensor, a plurality of blood glucose values of a user, and the processor receiving the values from the sensor. This amounts to no more than insignificant extra-solution activity in the form of pre-solution data gathering, and is not indicative of integration into a practical application. See MPEP 2106.05(g). The claims are directed to an abstract idea. The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional element of using hardware processors and a display to perform the claimed assigning, applying, receiving, determining and outputting steps amounts to no more than mere instructions to apply the exception using generic computer components. Mere instructions to apply an exception using a generic computer component cannot provide an inventive concept. Furthermore, as discussed above, measuring, using a glucose sensor, a plurality of blood glucose values of a user amounts to no more than insignificant extra-solution activity in the form of pre-solution data gathering. The claims are not patent eligible. Dependent claims 3-16 and 18-21 recite the same abstract idea as in their respective parent claims, and only recite additional details of the data being input to the processors and information provided to the user via the display, such as the user inputs, classification measurements, and recommendations and scores. Therefore, these claims do not recite additional limitations sufficient to direct the claimed invention to significantly more. Response to Arguments 3. Applicant’s arguments filed 30 March 2026 with respect to the section 101 rejection have been fully considered but they are not persuasive. Applicant argues that claims 2 and 17 recite a particular sensor-driven physiological data processing workflow that is more than mere data collection. This is not persuasive. The sensor is a generic glucose sensor that merely provides measurements used for analysis by the processor, and there is no other claimed connection between the sensor and processor. Applicant is directed to 2106.05(g), which states that similar examples such as “performing clinical tests on individuals to obtain input for an equation” in In re Grams constitute mere data gathering. Applicant also points to the assigning of GluScores and argues this represents an improvement to the sensor-processor arrangement. However, this appears to be directed instead to an improvement to the classification of an individual in order to provide more accurate recommendations to the user. This is not an improvement to the sensor or to any technical area. Applicant further argues that the particular series of steps results in an improvement to a technical area through the use of classifying and bias correction. Again, it is noted that the result of this series of steps does not otherwise affect the function of the sensor or the processor, and only results in an improvement to the recommendations provided to the user, which is an abstract idea itself. Applicant further argues that the use of the sensor and processor to perform the claimed steps cannot be performed in the human mind. This is not persuasive. Applicant has not shown how a person could not assign a classification, apply a bias correction, and determine a score, by observing values collected from a glucose sensor and making determinations and/or calculations based on the values. 5. Applicant’s arguments with respect to the section 102 and 103 rejections, in view of the corresponding amendments, have been fully considered and are persuasive. The section 102 and 103 rejections have been withdrawn. Shaya and the other prior art of record does not reasonably disclose or suggest the particular combination of steps performed in claim 2, including assigning a classification, applying a bias correction, and determining a score based on the bias-corrected plurality of values and input pertaining to a glucose-changing event. Conclusion 6. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. 7. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PETER EGLOFF whose telephone number is (571) 270-3548. The examiner can normally be reached 9:00 AM – 5:00 PM, Monday through Friday Eastern. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Xuan Thai, can be reached at 571-272-7147. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Peter R Egloff/ Primary Examiner, Art Unit 3715
Read full office action

Prosecution Timeline

Jun 26, 2024
Application Filed
Sep 09, 2024
Response after Non-Final Action
Dec 31, 2025
Non-Final Rejection mailed — §101
Mar 30, 2026
Response Filed
Jun 16, 2026
Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12682775
CHAT CARD ENGINE(S) FOR CONVERSATIONAL CHAT CARDS
2y 4m to grant Granted Jul 14, 2026
Patent 12673246
EQUESTRIAN RIDER TRAINING HARNESS
2y 1m to grant Granted Jul 07, 2026
Patent 12664906
IMMERSIVE INTERVIEW WITH REAL-TIME INTERACTIVE FEEDBACK IN AUGMENTED REALITY
2y 6m to grant Granted Jun 23, 2026
Patent 12640045
ELECTRONIC APPARATUS, METHOD FOR CONTROLLING ELECTRONIC APPARATUS, AND STORAGE MEDIUM
2y 7m to grant Granted May 26, 2026
Patent 12614472
SYSTEMS AND METHODS FOR ACCESSIBLE COMPUTER-USER SCENARIOS
3y 6m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
43%
Grant Probability
75%
With Interview (+32.5%)
3y 4m (~1y 3m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 786 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month